All News

Oral CGRP inhibitor atogepant significantly reduced monthly headache days and improved daily function in adults with 4 to 14 headaches per month.

The Pfizer-BioNTech COVID-19 vaccine is the first to receive full approval from the FDA.

Talking to the COVID-19 vaccine-hesitant folks in your circle can be difficult. These 8 slides offer some new and some tried and true tips on how to approach the topic

The novel prandial insulin formulation from Eli Lilly is now approved for administration via continuous subcutaneous insulin infusion with an insulin pump.

AAFP, citing the increased health threat posed by the SARS-CoV-2 Delta variant, is calling on the FDA to expand current EUA to include patients younger than 12 years.

Data from the CDC on the Delta variant and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

According to a new NIH-funded study, early administration of COVID-19 convalescent plasma in high-risk outpatients did not prevent disease progression.

COVID-19 patients after just 5 days or less in the hospital report new or worsened symptoms, impaired daily function, and significant financial loss.

How effective are the 3 authorized COVID-19 vaccines against SARS-CoV-2 infection? Virus variants? Get updated on the latest evidence in our quick slideshow.

The new indication for empagliflozin is to reduce risk of CV death and hospitalization for heart failure in patients with HFrEF,

Delta variant rising and vaccine immunity possibly on the wane are 2 reasons cited by state governors and city mayors for requiring full vaccination of health care personnel.

Data from the CDC on the Delta variant and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

In a new joint statement, the HHS officially recommends booster shots of mRNA COVID-19 vaccines and outlines plan to start rollout this fall.

The American College of Physicians urges clinicians to make sure adult patients, especially the most vulnerable, are protected against preventable diseases as COVID spreads and flu is imminent.

Recommendation for a COVID-19 booster for vaccinated Americans could come by Wednesday; some experts say data are too sparse to support the move.

A new study suggests that walking even 3 or 4 hours a week may reduce long-term mortality from any cause in patients with a history of stroke.

Data from the CDC on the Delta variant and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Delaying or forfeiting care for HF significantly increased future health care costs, a finding at odds, say study authors, with the inability to afford regular treatment.